24
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology.

      Pharmacological reviews
      Animals, Basic Helix-Loop-Helix Transcription Factors, agonists, antagonists & inhibitors, chemistry, metabolism, Cell Differentiation, drug effects, Gastrointestinal Tract, immunology, microbiology, physiology, Humans, Immunity, Cellular, Immunity, Innate, Ligands, Lung, Models, Biological, Receptors, Aryl Hydrocarbon, Signal Transduction, Skin, Skin Physiological Phenomena, Xenobiotics, toxicity

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aryl hydrocarbon receptor (AhR) is an evolutionarily old transcription factor belonging to the Per-ARNT-Sim-basic helix-loop-helix protein family. AhR translocates into the nucleus upon binding of various small molecules into the pocket of its single-ligand binding domain. AhR binding to both xenobiotic and endogenous ligands results in highly cell-specific transcriptome changes and in changes in cellular functions. We discuss here the role of AhR for immune cells of the barrier organs: skin, gut, and lung. Both adaptive and innate immune cells require AhR signaling at critical checkpoints. We also discuss the current two prevailing views-namely, 1) AhR as a promiscuous sensor for small chemicals and 2) a role for AhR as a balancing factor for cell differentiation and function, which is controlled by levels of endogenous high-affinity ligands. AhR signaling is considered a promising drug and preventive target, particularly for cancer, inflammatory, and autoimmune diseases. Therefore, understanding its biology is of great importance. Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

          Related collections

          Author and article information

          Comments

          Comment on this article